首页> 外文OA文献 >Hepatoprotective Effects of Chinese Medicine Herbs Decoction on Liver Cirrhosis in Rats
【2h】

Hepatoprotective Effects of Chinese Medicine Herbs Decoction on Liver Cirrhosis in Rats

机译:中草药汤对大鼠肝硬化的保肝作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatoprotective and curative activities of aqueous extract of decoction containing 10 Chinese medicinal herbs (HPE-XA-08) were evaluated in Sprague–Dawley albino rats with liver damage induced by thioacetamide (TAA). These activities were assessed by investigating the liver enzymes level and also histopathology investigation. Increases in alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) levels were observed in rats with cirrhotic liver. No significant alterations of the liver enzymes were observed following treatment with HPE-XA-08. Histopathology examination of rats treated with HPE-XA-08 at 250 mg/kg body weight, however, exhibited moderate liver protective effects. Reduced extracellular matrix (ECM) proteins within the hepatocytes were noted in comparison to the cirrhotic liver. The curative effects of HPE-XA-08 were observed with marked decrease in the level of ALP (more than 3x) and level of GGT (more than 2x) in cirrhotic rat treated with 600 mg/kg body weight HPE-XA-08 in comparison to cirrhotic rat treated with just water diluent. Reversion of cirrhotic liver to normal liver condition in rats treated with HPE-XA-08 was observed. Results from the present study suggest that HPE-XA-08 treatment assisted in the protection from liver cirrhosis and improved the recovery of cirrhotic liver.
机译:在含有硫代乙酰胺(TAA)致肝损伤的Sprague-Dawley白化病大鼠中评估了含有10种中草药的水煎液(HPE-XA-08)的保肝和治疗活性。通过研究肝酶水平和组织病理学研究评估了这些活性。肝硬化大鼠的碱性磷酸酶(ALP)和γ-谷氨酰转移酶(GGT)水平升高。用HPE-XA-08处理后未观察到肝酶的显着变化。用HPE-XA-08以250μmg/ kg体重治疗的大鼠的组织病理学检查显示出中等的肝脏保护作用。与肝硬化的肝相比,肝细胞内的细胞外基质(ECM)蛋白减少。在以600 ofmg / kg体重的HPE-XA-08处理的肝硬化大鼠中,观察到HPE-XA-08的疗效显着降低ALP(超过3倍)和GGT(超过2x)。与仅用水稀释剂治疗的肝硬化大鼠比较。在用HPE-XA-08处理的大鼠中,观察到肝硬化肝恢复到正常肝状态。本研究的结果表明,HPE-XA-08治疗有助于预防肝硬化并改善肝硬化肝的恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号